Global Model Species Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Model Species market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 and Russia-Ukraine War influence, the global Model Species market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period.
The Model Species market in the USA. is estimated at USD million in 2022, which currently accounts for a % share in the global market. China, the world`s second largest economy, is estimated at USD million in 2022 and holds a % percent.
Drug Discovery occupied for % of the Model Species global market in 2021, and it is projected to value USD million by 2028, growing at a % CAGR in next six years. In terms of product type, Rat segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Model Species include Shanghai Model Organisms Center, Inc., Gem Pharmatech Co., Ltd., Charles River Laboratories, Envigo and Taconic Biosciences, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Key Features of This Report:
This report provides in-depth analysis of the global Model Species market, and provides market size and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year.
Main Model Species companies’ industry ranking, revenue, and market share analysis. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This reports profiles key players in the global Model Species market based on the following parameters – headquarters, products portfolio, Model Species revenue and gross margin, recent developments.
Evaluation and forecast the Model Species market size, projected growth trends, and corresponding market share analysis by type, by application and by region. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
Highlights of the current market scenario, recent information, latest developments, and factors impacting the growth of the market
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Market segmentation
Model Species market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of revenue. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type (2017-2028; USD Million)
Chapter 1, to describe Model Species product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Model Species, with revenue, gross margin and global market share of Model Species from 2019 to 2022.
Chapter 3, the Model Species competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Model Species market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Model Species research findings and conclusion, appendix and data source.
According to our (Global Info Research) latest study, due to COVID-19 and Russia-Ukraine War influence, the global Model Species market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period.
The Model Species market in the USA. is estimated at USD million in 2022, which currently accounts for a % share in the global market. China, the world`s second largest economy, is estimated at USD million in 2022 and holds a % percent.
Drug Discovery occupied for % of the Model Species global market in 2021, and it is projected to value USD million by 2028, growing at a % CAGR in next six years. In terms of product type, Rat segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Model Species include Shanghai Model Organisms Center, Inc., Gem Pharmatech Co., Ltd., Charles River Laboratories, Envigo and Taconic Biosciences, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Key Features of This Report:
This report provides in-depth analysis of the global Model Species market, and provides market size and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year.
Main Model Species companies’ industry ranking, revenue, and market share analysis. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This reports profiles key players in the global Model Species market based on the following parameters – headquarters, products portfolio, Model Species revenue and gross margin, recent developments.
Evaluation and forecast the Model Species market size, projected growth trends, and corresponding market share analysis by type, by application and by region. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
Highlights of the current market scenario, recent information, latest developments, and factors impacting the growth of the market
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Market segmentation
Model Species market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of revenue. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type (2017-2028; USD Million)
- Rat
- Mouse
- Zebrafish
- Arabidopsis Thaliana
- Others
- Drug Discovery
- Basic Research
- Toxicity Test
- Parasitological Study
- Hereditary Disease Study
- Shanghai Model Organisms Center, Inc.
- Gem Pharmatech Co., Ltd.
- Charles River Laboratories
- Envigo
- Taconic Biosciences
- Jackson Laboratory
- Shanghai SLAC
- Joinn Laboratories
- Crown Biosciences
- Pharmalegacy
- Syngene International
- Janvier Labs
- GenOway
- Psychogenics
- Horizon Discovery Group
- Vitalstar Biotechnology
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Australia)
- South America (Brazil, Argentina, Colombia and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa and Rest of Middle East & Africa)
Chapter 1, to describe Model Species product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Model Species, with revenue, gross margin and global market share of Model Species from 2019 to 2022.
Chapter 3, the Model Species competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Model Species market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Model Species research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Model Species
1.2 Classification of Model Species by Type
1.2.1 Overview: Global Model Species Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Model Species Revenue Market Share by Type in 2021
1.2.3 Rat
1.2.4 Mouse
1.2.5 Zebrafish
1.2.6 Arabidopsis Thaliana
1.2.7 Others
1.3 Global Model Species Market by Application
1.3.1 Overview: Global Model Species Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Drug Discovery
1.3.3 Basic Research
1.3.4 Toxicity Test
1.3.5 Parasitological Study
1.3.6 Hereditary Disease Study
1.4 Global Model Species Market Size & Forecast
1.5 Global Model Species Market Size and Forecast by Region
1.5.1 Global Model Species Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Model Species Market Size by Region, (2017-2022)
1.5.3 North America Model Species Market Size and Prospect (2017-2028)
1.5.4 Europe Model Species Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Model Species Market Size and Prospect (2017-2028)
1.5.6 South America Model Species Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Model Species Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Model Species Market Drivers
1.6.2 Model Species Market Restraints
1.6.3 Model Species Trends Analysis
2 COMPANY PROFILES
2.1 Shanghai Model Organisms Center, Inc.
2.1.1 Shanghai Model Organisms Center, Inc. Details
2.1.2 Shanghai Model Organisms Center, Inc. Major Business
2.1.3 Shanghai Model Organisms Center, Inc. Model Species Product and Solutions
2.1.4 Shanghai Model Organisms Center, Inc. Model Species Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Shanghai Model Organisms Center, Inc. Recent Developments and Future Plans
2.2 Gem Pharmatech Co., Ltd.
2.2.1 Gem Pharmatech Co., Ltd. Details
2.2.2 Gem Pharmatech Co., Ltd. Major Business
2.2.3 Gem Pharmatech Co., Ltd. Model Species Product and Solutions
2.2.4 Gem Pharmatech Co., Ltd. Model Species Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Gem Pharmatech Co., Ltd. Recent Developments and Future Plans
2.3 Charles River Laboratories
2.3.1 Charles River Laboratories Details
2.3.2 Charles River Laboratories Major Business
2.3.3 Charles River Laboratories Model Species Product and Solutions
2.3.4 Charles River Laboratories Model Species Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Charles River Laboratories Recent Developments and Future Plans
2.4 Envigo
2.4.1 Envigo Details
2.4.2 Envigo Major Business
2.4.3 Envigo Model Species Product and Solutions
2.4.4 Envigo Model Species Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Envigo Recent Developments and Future Plans
2.5 Taconic Biosciences
2.5.1 Taconic Biosciences Details
2.5.2 Taconic Biosciences Major Business
2.5.3 Taconic Biosciences Model Species Product and Solutions
2.5.4 Taconic Biosciences Model Species Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Taconic Biosciences Recent Developments and Future Plans
2.6 Jackson Laboratory
2.6.1 Jackson Laboratory Details
2.6.2 Jackson Laboratory Major Business
2.6.3 Jackson Laboratory Model Species Product and Solutions
2.6.4 Jackson Laboratory Model Species Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Jackson Laboratory Recent Developments and Future Plans
2.7 Shanghai SLAC
2.7.1 Shanghai SLAC Details
2.7.2 Shanghai SLAC Major Business
2.7.3 Shanghai SLAC Model Species Product and Solutions
2.7.4 Shanghai SLAC Model Species Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Shanghai SLAC Recent Developments and Future Plans
2.8 Joinn Laboratories
2.8.1 Joinn Laboratories Details
2.8.2 Joinn Laboratories Major Business
2.8.3 Joinn Laboratories Model Species Product and Solutions
2.8.4 Joinn Laboratories Model Species Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Joinn Laboratories Recent Developments and Future Plans
2.9 Crown Biosciences
2.9.1 Crown Biosciences Details
2.9.2 Crown Biosciences Major Business
2.9.3 Crown Biosciences Model Species Product and Solutions
2.9.4 Crown Biosciences Model Species Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Crown Biosciences Recent Developments and Future Plans
2.10 Pharmalegacy
2.10.1 Pharmalegacy Details
2.10.2 Pharmalegacy Major Business
2.10.3 Pharmalegacy Model Species Product and Solutions
2.10.4 Pharmalegacy Model Species Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Pharmalegacy Recent Developments and Future Plans
2.11 Syngene International
2.11.1 Syngene International Details
2.11.2 Syngene International Major Business
2.11.3 Syngene International Model Species Product and Solutions
2.11.4 Syngene International Model Species Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Syngene International Recent Developments and Future Plans
2.12 Janvier Labs
2.12.1 Janvier Labs Details
2.12.2 Janvier Labs Major Business
2.12.3 Janvier Labs Model Species Product and Solutions
2.12.4 Janvier Labs Model Species Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Janvier Labs Recent Developments and Future Plans
2.13 GenOway
2.13.1 GenOway Details
2.13.2 GenOway Major Business
2.13.3 GenOway Model Species Product and Solutions
2.13.4 GenOway Model Species Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 GenOway Recent Developments and Future Plans
2.14 Psychogenics
2.14.1 Psychogenics Details
2.14.2 Psychogenics Major Business
2.14.3 Psychogenics Model Species Product and Solutions
2.14.4 Psychogenics Model Species Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Psychogenics Recent Developments and Future Plans
2.15 Horizon Discovery Group
2.15.1 Horizon Discovery Group Details
2.15.2 Horizon Discovery Group Major Business
2.15.3 Horizon Discovery Group Model Species Product and Solutions
2.15.4 Horizon Discovery Group Model Species Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Horizon Discovery Group Recent Developments and Future Plans
2.16 Vitalstar Biotechnology
2.16.1 Vitalstar Biotechnology Details
2.16.2 Vitalstar Biotechnology Major Business
2.16.3 Vitalstar Biotechnology Model Species Product and Solutions
2.16.4 Vitalstar Biotechnology Model Species Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Vitalstar Biotechnology Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Model Species Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Model Species Players Market Share in 2021
3.2.2 Top 10 Model Species Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Model Species Players Head Office, Products and Services Provided
3.4 Model Species Mergers & Acquisitions
3.5 Model Species New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Model Species Revenue and Market Share by Type (2017-2022)
4.2 Global Model Species Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Model Species Revenue Market Share by Application (2017-2022)
5.2 Global Model Species Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Model Species Revenue by Type (2017-2028)
6.2 North America Model Species Revenue by Application (2017-2028)
6.3 North America Model Species Market Size by Country
6.3.1 North America Model Species Revenue by Country (2017-2028)
6.3.2 United States Model Species Market Size and Forecast (2017-2028)
6.3.3 Canada Model Species Market Size and Forecast (2017-2028)
6.3.4 Mexico Model Species Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Model Species Revenue by Type (2017-2028)
7.2 Europe Model Species Revenue by Application (2017-2028)
7.3 Europe Model Species Market Size by Country
7.3.1 Europe Model Species Revenue by Country (2017-2028)
7.3.2 Germany Model Species Market Size and Forecast (2017-2028)
7.3.3 France Model Species Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Model Species Market Size and Forecast (2017-2028)
7.3.5 Russia Model Species Market Size and Forecast (2017-2028)
7.3.6 Italy Model Species Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Model Species Revenue by Type (2017-2028)
8.2 Asia-Pacific Model Species Revenue by Application (2017-2028)
8.3 Asia-Pacific Model Species Market Size by Region
8.3.1 Asia-Pacific Model Species Revenue by Region (2017-2028)
8.3.2 China Model Species Market Size and Forecast (2017-2028)
8.3.3 Japan Model Species Market Size and Forecast (2017-2028)
8.3.4 South Korea Model Species Market Size and Forecast (2017-2028)
8.3.5 India Model Species Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Model Species Market Size and Forecast (2017-2028)
8.3.7 Australia Model Species Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Model Species Revenue by Type (2017-2028)
9.2 South America Model Species Revenue by Application (2017-2028)
9.3 South America Model Species Market Size by Country
9.3.1 South America Model Species Revenue by Country (2017-2028)
9.3.2 Brazil Model Species Market Size and Forecast (2017-2028)
9.3.3 Argentina Model Species Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Model Species Revenue by Type (2017-2028)
10.2 Middle East & Africa Model Species Revenue by Application (2017-2028)
10.3 Middle East & Africa Model Species Market Size by Country
10.3.1 Middle East & Africa Model Species Revenue by Country (2017-2028)
10.3.2 Turkey Model Species Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Model Species Market Size and Forecast (2017-2028)
10.3.4 UAE Model Species Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Product Overview and Scope of Model Species
1.2 Classification of Model Species by Type
1.2.1 Overview: Global Model Species Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Model Species Revenue Market Share by Type in 2021
1.2.3 Rat
1.2.4 Mouse
1.2.5 Zebrafish
1.2.6 Arabidopsis Thaliana
1.2.7 Others
1.3 Global Model Species Market by Application
1.3.1 Overview: Global Model Species Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Drug Discovery
1.3.3 Basic Research
1.3.4 Toxicity Test
1.3.5 Parasitological Study
1.3.6 Hereditary Disease Study
1.4 Global Model Species Market Size & Forecast
1.5 Global Model Species Market Size and Forecast by Region
1.5.1 Global Model Species Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Model Species Market Size by Region, (2017-2022)
1.5.3 North America Model Species Market Size and Prospect (2017-2028)
1.5.4 Europe Model Species Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Model Species Market Size and Prospect (2017-2028)
1.5.6 South America Model Species Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Model Species Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Model Species Market Drivers
1.6.2 Model Species Market Restraints
1.6.3 Model Species Trends Analysis
2 COMPANY PROFILES
2.1 Shanghai Model Organisms Center, Inc.
2.1.1 Shanghai Model Organisms Center, Inc. Details
2.1.2 Shanghai Model Organisms Center, Inc. Major Business
2.1.3 Shanghai Model Organisms Center, Inc. Model Species Product and Solutions
2.1.4 Shanghai Model Organisms Center, Inc. Model Species Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Shanghai Model Organisms Center, Inc. Recent Developments and Future Plans
2.2 Gem Pharmatech Co., Ltd.
2.2.1 Gem Pharmatech Co., Ltd. Details
2.2.2 Gem Pharmatech Co., Ltd. Major Business
2.2.3 Gem Pharmatech Co., Ltd. Model Species Product and Solutions
2.2.4 Gem Pharmatech Co., Ltd. Model Species Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Gem Pharmatech Co., Ltd. Recent Developments and Future Plans
2.3 Charles River Laboratories
2.3.1 Charles River Laboratories Details
2.3.2 Charles River Laboratories Major Business
2.3.3 Charles River Laboratories Model Species Product and Solutions
2.3.4 Charles River Laboratories Model Species Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Charles River Laboratories Recent Developments and Future Plans
2.4 Envigo
2.4.1 Envigo Details
2.4.2 Envigo Major Business
2.4.3 Envigo Model Species Product and Solutions
2.4.4 Envigo Model Species Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Envigo Recent Developments and Future Plans
2.5 Taconic Biosciences
2.5.1 Taconic Biosciences Details
2.5.2 Taconic Biosciences Major Business
2.5.3 Taconic Biosciences Model Species Product and Solutions
2.5.4 Taconic Biosciences Model Species Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Taconic Biosciences Recent Developments and Future Plans
2.6 Jackson Laboratory
2.6.1 Jackson Laboratory Details
2.6.2 Jackson Laboratory Major Business
2.6.3 Jackson Laboratory Model Species Product and Solutions
2.6.4 Jackson Laboratory Model Species Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Jackson Laboratory Recent Developments and Future Plans
2.7 Shanghai SLAC
2.7.1 Shanghai SLAC Details
2.7.2 Shanghai SLAC Major Business
2.7.3 Shanghai SLAC Model Species Product and Solutions
2.7.4 Shanghai SLAC Model Species Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Shanghai SLAC Recent Developments and Future Plans
2.8 Joinn Laboratories
2.8.1 Joinn Laboratories Details
2.8.2 Joinn Laboratories Major Business
2.8.3 Joinn Laboratories Model Species Product and Solutions
2.8.4 Joinn Laboratories Model Species Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Joinn Laboratories Recent Developments and Future Plans
2.9 Crown Biosciences
2.9.1 Crown Biosciences Details
2.9.2 Crown Biosciences Major Business
2.9.3 Crown Biosciences Model Species Product and Solutions
2.9.4 Crown Biosciences Model Species Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Crown Biosciences Recent Developments and Future Plans
2.10 Pharmalegacy
2.10.1 Pharmalegacy Details
2.10.2 Pharmalegacy Major Business
2.10.3 Pharmalegacy Model Species Product and Solutions
2.10.4 Pharmalegacy Model Species Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Pharmalegacy Recent Developments and Future Plans
2.11 Syngene International
2.11.1 Syngene International Details
2.11.2 Syngene International Major Business
2.11.3 Syngene International Model Species Product and Solutions
2.11.4 Syngene International Model Species Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Syngene International Recent Developments and Future Plans
2.12 Janvier Labs
2.12.1 Janvier Labs Details
2.12.2 Janvier Labs Major Business
2.12.3 Janvier Labs Model Species Product and Solutions
2.12.4 Janvier Labs Model Species Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Janvier Labs Recent Developments and Future Plans
2.13 GenOway
2.13.1 GenOway Details
2.13.2 GenOway Major Business
2.13.3 GenOway Model Species Product and Solutions
2.13.4 GenOway Model Species Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 GenOway Recent Developments and Future Plans
2.14 Psychogenics
2.14.1 Psychogenics Details
2.14.2 Psychogenics Major Business
2.14.3 Psychogenics Model Species Product and Solutions
2.14.4 Psychogenics Model Species Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Psychogenics Recent Developments and Future Plans
2.15 Horizon Discovery Group
2.15.1 Horizon Discovery Group Details
2.15.2 Horizon Discovery Group Major Business
2.15.3 Horizon Discovery Group Model Species Product and Solutions
2.15.4 Horizon Discovery Group Model Species Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Horizon Discovery Group Recent Developments and Future Plans
2.16 Vitalstar Biotechnology
2.16.1 Vitalstar Biotechnology Details
2.16.2 Vitalstar Biotechnology Major Business
2.16.3 Vitalstar Biotechnology Model Species Product and Solutions
2.16.4 Vitalstar Biotechnology Model Species Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Vitalstar Biotechnology Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Model Species Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Model Species Players Market Share in 2021
3.2.2 Top 10 Model Species Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Model Species Players Head Office, Products and Services Provided
3.4 Model Species Mergers & Acquisitions
3.5 Model Species New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Model Species Revenue and Market Share by Type (2017-2022)
4.2 Global Model Species Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Model Species Revenue Market Share by Application (2017-2022)
5.2 Global Model Species Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Model Species Revenue by Type (2017-2028)
6.2 North America Model Species Revenue by Application (2017-2028)
6.3 North America Model Species Market Size by Country
6.3.1 North America Model Species Revenue by Country (2017-2028)
6.3.2 United States Model Species Market Size and Forecast (2017-2028)
6.3.3 Canada Model Species Market Size and Forecast (2017-2028)
6.3.4 Mexico Model Species Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Model Species Revenue by Type (2017-2028)
7.2 Europe Model Species Revenue by Application (2017-2028)
7.3 Europe Model Species Market Size by Country
7.3.1 Europe Model Species Revenue by Country (2017-2028)
7.3.2 Germany Model Species Market Size and Forecast (2017-2028)
7.3.3 France Model Species Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Model Species Market Size and Forecast (2017-2028)
7.3.5 Russia Model Species Market Size and Forecast (2017-2028)
7.3.6 Italy Model Species Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Model Species Revenue by Type (2017-2028)
8.2 Asia-Pacific Model Species Revenue by Application (2017-2028)
8.3 Asia-Pacific Model Species Market Size by Region
8.3.1 Asia-Pacific Model Species Revenue by Region (2017-2028)
8.3.2 China Model Species Market Size and Forecast (2017-2028)
8.3.3 Japan Model Species Market Size and Forecast (2017-2028)
8.3.4 South Korea Model Species Market Size and Forecast (2017-2028)
8.3.5 India Model Species Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Model Species Market Size and Forecast (2017-2028)
8.3.7 Australia Model Species Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Model Species Revenue by Type (2017-2028)
9.2 South America Model Species Revenue by Application (2017-2028)
9.3 South America Model Species Market Size by Country
9.3.1 South America Model Species Revenue by Country (2017-2028)
9.3.2 Brazil Model Species Market Size and Forecast (2017-2028)
9.3.3 Argentina Model Species Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Model Species Revenue by Type (2017-2028)
10.2 Middle East & Africa Model Species Revenue by Application (2017-2028)
10.3 Middle East & Africa Model Species Market Size by Country
10.3.1 Middle East & Africa Model Species Revenue by Country (2017-2028)
10.3.2 Turkey Model Species Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Model Species Market Size and Forecast (2017-2028)
10.3.4 UAE Model Species Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. Global Model Species Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Model Species Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Model Species Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Model Species Revenue (USD Million) by Region (2017-2022)
Table 5. Global Model Species Revenue Market Share by Region (2023-2028)
Table 6. Shanghai Model Organisms Center, Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Shanghai Model Organisms Center, Inc. Major Business
Table 8. Shanghai Model Organisms Center, Inc. Model Species Product and Solutions
Table 9. Shanghai Model Organisms Center, Inc. Model Species Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Gem Pharmatech Co., Ltd. Corporate Information, Head Office, and Major Competitors
Table 11. Gem Pharmatech Co., Ltd. Major Business
Table 12. Gem Pharmatech Co., Ltd. Model Species Product and Solutions
Table 13. Gem Pharmatech Co., Ltd. Model Species Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Charles River Laboratories Corporate Information, Head Office, and Major Competitors
Table 15. Charles River Laboratories Major Business
Table 16. Charles River Laboratories Model Species Product and Solutions
Table 17. Charles River Laboratories Model Species Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Envigo Corporate Information, Head Office, and Major Competitors
Table 19. Envigo Major Business
Table 20. Envigo Model Species Product and Solutions
Table 21. Envigo Model Species Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Taconic Biosciences Corporate Information, Head Office, and Major Competitors
Table 23. Taconic Biosciences Major Business
Table 24. Taconic Biosciences Model Species Product and Solutions
Table 25. Taconic Biosciences Model Species Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Jackson Laboratory Corporate Information, Head Office, and Major Competitors
Table 27. Jackson Laboratory Major Business
Table 28. Jackson Laboratory Model Species Product and Solutions
Table 29. Jackson Laboratory Model Species Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Shanghai SLAC Corporate Information, Head Office, and Major Competitors
Table 31. Shanghai SLAC Major Business
Table 32. Shanghai SLAC Model Species Product and Solutions
Table 33. Shanghai SLAC Model Species Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Joinn Laboratories Corporate Information, Head Office, and Major Competitors
Table 35. Joinn Laboratories Major Business
Table 36. Joinn Laboratories Model Species Product and Solutions
Table 37. Joinn Laboratories Model Species Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Crown Biosciences Corporate Information, Head Office, and Major Competitors
Table 39. Crown Biosciences Major Business
Table 40. Crown Biosciences Model Species Product and Solutions
Table 41. Crown Biosciences Model Species Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Pharmalegacy Corporate Information, Head Office, and Major Competitors
Table 43. Pharmalegacy Major Business
Table 44. Pharmalegacy Model Species Product and Solutions
Table 45. Pharmalegacy Model Species Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Syngene International Corporate Information, Head Office, and Major Competitors
Table 47. Syngene International Major Business
Table 48. Syngene International Model Species Product and Solutions
Table 49. Syngene International Model Species Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Janvier Labs Corporate Information, Head Office, and Major Competitors
Table 51. Janvier Labs Major Business
Table 52. Janvier Labs Model Species Product and Solutions
Table 53. Janvier Labs Model Species Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. GenOway Corporate Information, Head Office, and Major Competitors
Table 55. GenOway Major Business
Table 56. GenOway Model Species Product and Solutions
Table 57. GenOway Model Species Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Psychogenics Corporate Information, Head Office, and Major Competitors
Table 59. Psychogenics Major Business
Table 60. Psychogenics Model Species Product and Solutions
Table 61. Psychogenics Model Species Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Horizon Discovery Group Corporate Information, Head Office, and Major Competitors
Table 63. Horizon Discovery Group Major Business
Table 64. Horizon Discovery Group Model Species Product and Solutions
Table 65. Horizon Discovery Group Model Species Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Vitalstar Biotechnology Corporate Information, Head Office, and Major Competitors
Table 67. Vitalstar Biotechnology Major Business
Table 68. Vitalstar Biotechnology Model Species Product and Solutions
Table 69. Vitalstar Biotechnology Model Species Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Global Model Species Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 71. Global Model Species Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 72. Breakdown of Model Species by Company Type (Tier 1, Tier 2 and Tier 3)
Table 73. Model Species Players Head Office, Products and Services Provided
Table 74. Model Species Mergers & Acquisitions in the Past Five Years
Table 75. Model Species New Entrants and Expansion Plans
Table 76. Global Model Species Revenue (USD Million) by Type (2017-2022)
Table 77. Global Model Species Revenue Share by Type (2017-2022)
Table 78. Global Model Species Revenue Forecast by Type (2023-2028)
Table 79. Global Model Species Revenue by Application (2017-2022)
Table 80. Global Model Species Revenue Forecast by Application (2023-2028)
Table 81. North America Model Species Revenue by Type (2017-2022) & (USD Million)
Table 82. North America Model Species Revenue by Type (2023-2028) & (USD Million)
Table 83. North America Model Species Revenue by Application (2017-2022) & (USD Million)
Table 84. North America Model Species Revenue by Application (2023-2028) & (USD Million)
Table 85. North America Model Species Revenue by Country (2017-2022) & (USD Million)
Table 86. North America Model Species Revenue by Country (2023-2028) & (USD Million)
Table 87. Europe Model Species Revenue by Type (2017-2022) & (USD Million)
Table 88. Europe Model Species Revenue by Type (2023-2028) & (USD Million)
Table 89. Europe Model Species Revenue by Application (2017-2022) & (USD Million)
Table 90. Europe Model Species Revenue by Application (2023-2028) & (USD Million)
Table 91. Europe Model Species Revenue by Country (2017-2022) & (USD Million)
Table 92. Europe Model Species Revenue by Country (2023-2028) & (USD Million)
Table 93. Asia-Pacific Model Species Revenue by Type (2017-2022) & (USD Million)
Table 94. Asia-Pacific Model Species Revenue by Type (2023-2028) & (USD Million)
Table 95. Asia-Pacific Model Species Revenue by Application (2017-2022) & (USD Million)
Table 96. Asia-Pacific Model Species Revenue by Application (2023-2028) & (USD Million)
Table 97. Asia-Pacific Model Species Revenue by Region (2017-2022) & (USD Million)
Table 98. Asia-Pacific Model Species Revenue by Region (2023-2028) & (USD Million)
Table 99. South America Model Species Revenue by Type (2017-2022) & (USD Million)
Table 100. South America Model Species Revenue by Type (2023-2028) & (USD Million)
Table 101. South America Model Species Revenue by Application (2017-2022) & (USD Million)
Table 102. South America Model Species Revenue by Application (2023-2028) & (USD Million)
Table 103. South America Model Species Revenue by Country (2017-2022) & (USD Million)
Table 104. South America Model Species Revenue by Country (2023-2028) & (USD Million)
Table 105. Middle East & Africa Model Species Revenue by Type (2017-2022) & (USD Million)
Table 106. Middle East & Africa Model Species Revenue by Type (2023-2028) & (USD Million)
Table 107. Middle East & Africa Model Species Revenue by Application (2017-2022) & (USD Million)
Table 108. Middle East & Africa Model Species Revenue by Application (2023-2028) & (USD Million)
Table 109. Middle East & Africa Model Species Revenue by Country (2017-2022) & (USD Million)
Table 110. Middle East & Africa Model Species Revenue by Country (2023-2028) & (USD Million)
Table 1. Global Model Species Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Model Species Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Model Species Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Model Species Revenue (USD Million) by Region (2017-2022)
Table 5. Global Model Species Revenue Market Share by Region (2023-2028)
Table 6. Shanghai Model Organisms Center, Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Shanghai Model Organisms Center, Inc. Major Business
Table 8. Shanghai Model Organisms Center, Inc. Model Species Product and Solutions
Table 9. Shanghai Model Organisms Center, Inc. Model Species Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Gem Pharmatech Co., Ltd. Corporate Information, Head Office, and Major Competitors
Table 11. Gem Pharmatech Co., Ltd. Major Business
Table 12. Gem Pharmatech Co., Ltd. Model Species Product and Solutions
Table 13. Gem Pharmatech Co., Ltd. Model Species Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Charles River Laboratories Corporate Information, Head Office, and Major Competitors
Table 15. Charles River Laboratories Major Business
Table 16. Charles River Laboratories Model Species Product and Solutions
Table 17. Charles River Laboratories Model Species Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Envigo Corporate Information, Head Office, and Major Competitors
Table 19. Envigo Major Business
Table 20. Envigo Model Species Product and Solutions
Table 21. Envigo Model Species Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Taconic Biosciences Corporate Information, Head Office, and Major Competitors
Table 23. Taconic Biosciences Major Business
Table 24. Taconic Biosciences Model Species Product and Solutions
Table 25. Taconic Biosciences Model Species Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Jackson Laboratory Corporate Information, Head Office, and Major Competitors
Table 27. Jackson Laboratory Major Business
Table 28. Jackson Laboratory Model Species Product and Solutions
Table 29. Jackson Laboratory Model Species Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Shanghai SLAC Corporate Information, Head Office, and Major Competitors
Table 31. Shanghai SLAC Major Business
Table 32. Shanghai SLAC Model Species Product and Solutions
Table 33. Shanghai SLAC Model Species Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Joinn Laboratories Corporate Information, Head Office, and Major Competitors
Table 35. Joinn Laboratories Major Business
Table 36. Joinn Laboratories Model Species Product and Solutions
Table 37. Joinn Laboratories Model Species Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Crown Biosciences Corporate Information, Head Office, and Major Competitors
Table 39. Crown Biosciences Major Business
Table 40. Crown Biosciences Model Species Product and Solutions
Table 41. Crown Biosciences Model Species Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Pharmalegacy Corporate Information, Head Office, and Major Competitors
Table 43. Pharmalegacy Major Business
Table 44. Pharmalegacy Model Species Product and Solutions
Table 45. Pharmalegacy Model Species Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Syngene International Corporate Information, Head Office, and Major Competitors
Table 47. Syngene International Major Business
Table 48. Syngene International Model Species Product and Solutions
Table 49. Syngene International Model Species Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Janvier Labs Corporate Information, Head Office, and Major Competitors
Table 51. Janvier Labs Major Business
Table 52. Janvier Labs Model Species Product and Solutions
Table 53. Janvier Labs Model Species Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. GenOway Corporate Information, Head Office, and Major Competitors
Table 55. GenOway Major Business
Table 56. GenOway Model Species Product and Solutions
Table 57. GenOway Model Species Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Psychogenics Corporate Information, Head Office, and Major Competitors
Table 59. Psychogenics Major Business
Table 60. Psychogenics Model Species Product and Solutions
Table 61. Psychogenics Model Species Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Horizon Discovery Group Corporate Information, Head Office, and Major Competitors
Table 63. Horizon Discovery Group Major Business
Table 64. Horizon Discovery Group Model Species Product and Solutions
Table 65. Horizon Discovery Group Model Species Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Vitalstar Biotechnology Corporate Information, Head Office, and Major Competitors
Table 67. Vitalstar Biotechnology Major Business
Table 68. Vitalstar Biotechnology Model Species Product and Solutions
Table 69. Vitalstar Biotechnology Model Species Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Global Model Species Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 71. Global Model Species Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 72. Breakdown of Model Species by Company Type (Tier 1, Tier 2 and Tier 3)
Table 73. Model Species Players Head Office, Products and Services Provided
Table 74. Model Species Mergers & Acquisitions in the Past Five Years
Table 75. Model Species New Entrants and Expansion Plans
Table 76. Global Model Species Revenue (USD Million) by Type (2017-2022)
Table 77. Global Model Species Revenue Share by Type (2017-2022)
Table 78. Global Model Species Revenue Forecast by Type (2023-2028)
Table 79. Global Model Species Revenue by Application (2017-2022)
Table 80. Global Model Species Revenue Forecast by Application (2023-2028)
Table 81. North America Model Species Revenue by Type (2017-2022) & (USD Million)
Table 82. North America Model Species Revenue by Type (2023-2028) & (USD Million)
Table 83. North America Model Species Revenue by Application (2017-2022) & (USD Million)
Table 84. North America Model Species Revenue by Application (2023-2028) & (USD Million)
Table 85. North America Model Species Revenue by Country (2017-2022) & (USD Million)
Table 86. North America Model Species Revenue by Country (2023-2028) & (USD Million)
Table 87. Europe Model Species Revenue by Type (2017-2022) & (USD Million)
Table 88. Europe Model Species Revenue by Type (2023-2028) & (USD Million)
Table 89. Europe Model Species Revenue by Application (2017-2022) & (USD Million)
Table 90. Europe Model Species Revenue by Application (2023-2028) & (USD Million)
Table 91. Europe Model Species Revenue by Country (2017-2022) & (USD Million)
Table 92. Europe Model Species Revenue by Country (2023-2028) & (USD Million)
Table 93. Asia-Pacific Model Species Revenue by Type (2017-2022) & (USD Million)
Table 94. Asia-Pacific Model Species Revenue by Type (2023-2028) & (USD Million)
Table 95. Asia-Pacific Model Species Revenue by Application (2017-2022) & (USD Million)
Table 96. Asia-Pacific Model Species Revenue by Application (2023-2028) & (USD Million)
Table 97. Asia-Pacific Model Species Revenue by Region (2017-2022) & (USD Million)
Table 98. Asia-Pacific Model Species Revenue by Region (2023-2028) & (USD Million)
Table 99. South America Model Species Revenue by Type (2017-2022) & (USD Million)
Table 100. South America Model Species Revenue by Type (2023-2028) & (USD Million)
Table 101. South America Model Species Revenue by Application (2017-2022) & (USD Million)
Table 102. South America Model Species Revenue by Application (2023-2028) & (USD Million)
Table 103. South America Model Species Revenue by Country (2017-2022) & (USD Million)
Table 104. South America Model Species Revenue by Country (2023-2028) & (USD Million)
Table 105. Middle East & Africa Model Species Revenue by Type (2017-2022) & (USD Million)
Table 106. Middle East & Africa Model Species Revenue by Type (2023-2028) & (USD Million)
Table 107. Middle East & Africa Model Species Revenue by Application (2017-2022) & (USD Million)
Table 108. Middle East & Africa Model Species Revenue by Application (2023-2028) & (USD Million)
Table 109. Middle East & Africa Model Species Revenue by Country (2017-2022) & (USD Million)
Table 110. Middle East & Africa Model Species Revenue by Country (2023-2028) & (USD Million)
LIST OF FIGURES
Figure 1. Model Species Picture
Figure 2. Global Model Species Revenue Market Share by Type in 2021
Figure 3. Rat
Figure 4. Mouse
Figure 5. Zebrafish
Figure 6. Arabidopsis Thaliana
Figure 7. Others
Figure 8. Model Species Revenue Market Share by Application in 2021
Figure 9. Drug Discovery Picture
Figure 10. Basic Research Picture
Figure 11. Toxicity Test Picture
Figure 12. Parasitological Study Picture
Figure 13. Hereditary Disease Study Picture
Figure 14. Global Model Species Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 15. Global Model Species Revenue and Forecast (2017-2028) & (USD Million)
Figure 16. Global Model Species Revenue Market Share by Region (2017-2028)
Figure 17. Global Model Species Revenue Market Share by Region in 2021
Figure 18. North America Model Species Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Europe Model Species Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Asia-Pacific Model Species Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. South America Model Species Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Middle East and Africa Model Species Revenue (USD Million) and Growth Rate (2017-2028)
Figure 23. Model Species Market Drivers
Figure 24. Model Species Market Restraints
Figure 25. Model Species Market Trends
Figure 26. Shanghai Model Organisms Center, Inc. Recent Developments and Future Plans
Figure 27. Gem Pharmatech Co., Ltd. Recent Developments and Future Plans
Figure 28. Charles River Laboratories Recent Developments and Future Plans
Figure 29. Envigo Recent Developments and Future Plans
Figure 30. Taconic Biosciences Recent Developments and Future Plans
Figure 31. Jackson Laboratory Recent Developments and Future Plans
Figure 32. Shanghai SLAC Recent Developments and Future Plans
Figure 33. Joinn Laboratories Recent Developments and Future Plans
Figure 34. Crown Biosciences Recent Developments and Future Plans
Figure 35. Pharmalegacy Recent Developments and Future Plans
Figure 36. Syngene International Recent Developments and Future Plans
Figure 37. Janvier Labs Recent Developments and Future Plans
Figure 38. GenOway Recent Developments and Future Plans
Figure 39. Psychogenics Recent Developments and Future Plans
Figure 40. Horizon Discovery Group Recent Developments and Future Plans
Figure 41. Vitalstar Biotechnology Recent Developments and Future Plans
Figure 42. Global Model Species Revenue Share by Players in 2021
Figure 43. Model Species Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 44. Global Top 3 Players Model Species Revenue Market Share in 2021
Figure 45. Global Top 10 Players Model Species Revenue Market Share in 2021
Figure 46. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 47. Global Model Species Revenue Share by Type in 2021
Figure 48. Global Model Species Market Share Forecast by Type (2023-2028)
Figure 49. Global Model Species Revenue Share by Application in 2021
Figure 50. Global Model Species Market Share Forecast by Application (2023-2028)
Figure 51. North America Model Species Sales Market Share by Type (2017-2028)
Figure 52. North America Model Species Sales Market Share by Application (2017-2028)
Figure 53. North America Model Species Revenue Market Share by Country (2017-2028)
Figure 54. United States Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Canada Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Mexico Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Europe Model Species Sales Market Share by Type (2017-2028)
Figure 58. Europe Model Species Sales Market Share by Application (2017-2028)
Figure 59. Europe Model Species Revenue Market Share by Country (2017-2028)
Figure 60. Germany Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. France Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. United Kingdom Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Russia Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Italy Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Asia-Pacific Model Species Sales Market Share by Type (2017-2028)
Figure 66. Asia-Pacific Model Species Sales Market Share by Application (2017-2028)
Figure 67. Asia-Pacific Model Species Revenue Market Share by Region (2017-2028)
Figure 68. China Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Japan Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. South Korea Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. India Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Southeast Asia Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Australia Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South America Model Species Sales Market Share by Type (2017-2028)
Figure 75. South America Model Species Sales Market Share by Application (2017-2028)
Figure 76. South America Model Species Revenue Market Share by Country (2017-2028)
Figure 77. Brazil Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Argentina Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Middle East and Africa Model Species Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Model Species Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Model Species Revenue Market Share by Country (2017-2028)
Figure 82. Turkey Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Saudi Arabia Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. UAE Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 85. Methodology
Figure 86. Research Process and Data Source
Figure 1. Model Species Picture
Figure 2. Global Model Species Revenue Market Share by Type in 2021
Figure 3. Rat
Figure 4. Mouse
Figure 5. Zebrafish
Figure 6. Arabidopsis Thaliana
Figure 7. Others
Figure 8. Model Species Revenue Market Share by Application in 2021
Figure 9. Drug Discovery Picture
Figure 10. Basic Research Picture
Figure 11. Toxicity Test Picture
Figure 12. Parasitological Study Picture
Figure 13. Hereditary Disease Study Picture
Figure 14. Global Model Species Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 15. Global Model Species Revenue and Forecast (2017-2028) & (USD Million)
Figure 16. Global Model Species Revenue Market Share by Region (2017-2028)
Figure 17. Global Model Species Revenue Market Share by Region in 2021
Figure 18. North America Model Species Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Europe Model Species Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Asia-Pacific Model Species Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. South America Model Species Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Middle East and Africa Model Species Revenue (USD Million) and Growth Rate (2017-2028)
Figure 23. Model Species Market Drivers
Figure 24. Model Species Market Restraints
Figure 25. Model Species Market Trends
Figure 26. Shanghai Model Organisms Center, Inc. Recent Developments and Future Plans
Figure 27. Gem Pharmatech Co., Ltd. Recent Developments and Future Plans
Figure 28. Charles River Laboratories Recent Developments and Future Plans
Figure 29. Envigo Recent Developments and Future Plans
Figure 30. Taconic Biosciences Recent Developments and Future Plans
Figure 31. Jackson Laboratory Recent Developments and Future Plans
Figure 32. Shanghai SLAC Recent Developments and Future Plans
Figure 33. Joinn Laboratories Recent Developments and Future Plans
Figure 34. Crown Biosciences Recent Developments and Future Plans
Figure 35. Pharmalegacy Recent Developments and Future Plans
Figure 36. Syngene International Recent Developments and Future Plans
Figure 37. Janvier Labs Recent Developments and Future Plans
Figure 38. GenOway Recent Developments and Future Plans
Figure 39. Psychogenics Recent Developments and Future Plans
Figure 40. Horizon Discovery Group Recent Developments and Future Plans
Figure 41. Vitalstar Biotechnology Recent Developments and Future Plans
Figure 42. Global Model Species Revenue Share by Players in 2021
Figure 43. Model Species Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 44. Global Top 3 Players Model Species Revenue Market Share in 2021
Figure 45. Global Top 10 Players Model Species Revenue Market Share in 2021
Figure 46. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 47. Global Model Species Revenue Share by Type in 2021
Figure 48. Global Model Species Market Share Forecast by Type (2023-2028)
Figure 49. Global Model Species Revenue Share by Application in 2021
Figure 50. Global Model Species Market Share Forecast by Application (2023-2028)
Figure 51. North America Model Species Sales Market Share by Type (2017-2028)
Figure 52. North America Model Species Sales Market Share by Application (2017-2028)
Figure 53. North America Model Species Revenue Market Share by Country (2017-2028)
Figure 54. United States Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Canada Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Mexico Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Europe Model Species Sales Market Share by Type (2017-2028)
Figure 58. Europe Model Species Sales Market Share by Application (2017-2028)
Figure 59. Europe Model Species Revenue Market Share by Country (2017-2028)
Figure 60. Germany Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. France Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. United Kingdom Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Russia Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Italy Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Asia-Pacific Model Species Sales Market Share by Type (2017-2028)
Figure 66. Asia-Pacific Model Species Sales Market Share by Application (2017-2028)
Figure 67. Asia-Pacific Model Species Revenue Market Share by Region (2017-2028)
Figure 68. China Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Japan Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. South Korea Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. India Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Southeast Asia Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Australia Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South America Model Species Sales Market Share by Type (2017-2028)
Figure 75. South America Model Species Sales Market Share by Application (2017-2028)
Figure 76. South America Model Species Revenue Market Share by Country (2017-2028)
Figure 77. Brazil Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Argentina Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Middle East and Africa Model Species Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Model Species Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Model Species Revenue Market Share by Country (2017-2028)
Figure 82. Turkey Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Saudi Arabia Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. UAE Model Species Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 85. Methodology
Figure 86. Research Process and Data Source
